PL2012773T3 - Leki i zastosowania - Google Patents

Leki i zastosowania

Info

Publication number: PL2012773T3
Authority: PL; Poland
Prior art keywords: drugs
Prior art date: 2006-04-22

Application number

PL07863339T

Other languages

English (en)

Inventor

James M Frincke

Christopher L Reading

Original Assignee

Harbor Biosciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-04-22

Filing date

2007-04-23

Publication date

2012-12-31

2007-04-23 Application filed by Harbor Biosciences Inc filed Critical Harbor Biosciences Inc

2012-12-31 Publication of PL2012773T3 publication Critical patent/PL2012773T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Epidemiology (AREA)
Hematology (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL07863339T 2006-04-22 2007-04-23 Leki i zastosowania PL2012773T3 (pl)

Applications Claiming Priority (12)

Application Number	Priority Date	Filing Date	Title
US79379206P	2006-04-22	2006-04-22
US84311206P	2006-09-08	2006-09-08
US82556906P	2006-09-13	2006-09-13
US82556406P	2006-09-13	2006-09-13
US82984806P	2006-10-17	2006-10-17
US86639506P	2006-11-17	2006-11-17
US86670006P	2006-11-21	2006-11-21
US86804206P	2006-11-30	2006-11-30
US88500307P	2007-01-15	2007-01-15
US88805807P	2007-02-02	2007-02-02
EP07863339A EP2012773B1 (en)	2006-04-22	2007-04-23	Drugs and uses
PCT/US2007/067235 WO2008039566A2 (en)	2006-04-22	2007-04-23	Drugs and uses

Publications (1)

Publication Number	Publication Date
PL2012773T3 true PL2012773T3 (pl)	2012-12-31

Family

ID=39230844

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL12167186T PL2486924T3 (pl)	2006-04-22	2007-04-23	Leki i zastosowania
PL07863339T PL2012773T3 (pl)	2006-04-22	2007-04-23	Leki i zastosowania

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL12167186T PL2486924T3 (pl)	2006-04-22	2007-04-23	Leki i zastosowania

Country Status (13)

Country	Link
EP (2)	EP2012773B1 (pl)
JP (2)	JP5130591B2 (pl)
KR (1)	KR20080112413A (pl)
CN (1)	CN103211821A (pl)
AU (2)	AU2007300404B2 (pl)
CA (1)	CA2649940C (pl)
DK (2)	DK2012773T3 (pl)
EA (1)	EA200802167A1 (pl)
ES (2)	ES2389743T3 (pl)
HU (1)	HUE042925T2 (pl)
IL (1)	IL194751A0 (pl)
PL (2)	PL2486924T3 (pl)
WO (1)	WO2008039566A2 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8569275B2 (en)	2002-08-28	2013-10-29	Harbor Therapeutics, Inc.	Steroids having 7-oxgen and 17-heteroaryl substitution
US8217025B2 (en)	2006-11-17	2012-07-10	Harbor Therapeutics, Inc.	Drug screening and treatment methods
US8354396B2 (en)	2006-11-17	2013-01-15	Harbor Therapeutics, Inc.	Drug identification and treatment method
US8486926B2 (en)	2006-11-17	2013-07-16	Harbor Therapeutics, Inc.	Steroid tetrol solid state forms
JP2011511011A (ja) *	2008-02-05	2011-04-07	ハーバーバイオサイエンシーズ，インコーポレイテッド	医薬的固体状態形態
KR101545300B1 (ko)	2008-04-03	2015-08-18	하버 바이오사이언시즈 인코포레이티드	고체 형태의 약제
JP5709743B2 (ja) *	2008-06-06	2015-04-30	ハーバーセラピューティクス，インコーポレイテッド	１７−アルキニル−７−ヒドロキシステロイドおよび関連する化合物の調製方法
WO2011156673A2 (en) *	2010-06-10	2011-12-15	Isis Pharmaceuticals, Inc.	Modulation of phosphoenolpyruvate carboxykinase-mitochondrial (pepck-m) expression
CN103402523A (zh) *	2010-12-17	2013-11-20	哈博生物科学公司	甾族化合物四醇固体形式-2
US20150158903A1 (en) *	2011-09-08	2015-06-11	Sage Therapeutics, Inc.	Neuroactive steroids, compositions, and uses thereof
ITMI20121472A1 (it) *	2012-09-04	2014-03-05	Ind Chimica Srl	Processo per la preparazione di 11-metilen-18-metilestr-4-en-3,17-dione, utile come intermedio per la sintesi di molecole ad attivita' farmacologica
KR101687061B1 (ko) *	2014-02-25	2016-12-16	순천향대학교 산학협력단	나이에 따른 당뇨병 진단을 위한 글루코코르티코이드 수용체의 검출제제를 포함하는 타입 2 당뇨 진단 키트
CN105017361A (zh) *	2015-07-16	2015-11-04	湖北竹溪人福药业有限责任公司	一种去氢表雄酮的合成方法
CN113350359B (zh)	2017-12-29	2022-08-16	广州市赛普特医药科技股份有限公司	5α-雄甾-3β,5,6β-三醇在制备治疗出血性脑卒中药物中的应用
CN109369760B (zh) *	2018-12-18	2021-01-01	湖南科瑞生物制药股份有限公司	一种制备去氢甲基睾丸素的方法
CN109369761B (zh) *	2018-12-18	2021-01-01	湖南科瑞生物制药股份有限公司	一种去氢甲基睾丸素的制备方法
CN113318114B (zh) *	2020-02-28	2023-02-17	广州市赛普特医药科技股份有限公司	小分子化合物在治疗肺上皮细胞损伤和/或血管内皮细胞损伤介导的疾病中的用途
CN114195844B (zh) *	2021-12-29	2023-03-17	湖北武当安泰药业有限公司	一种去氢表雄酮的制备方法
US11977085B1 (en)	2023-09-05	2024-05-07	Elan Ehrlich	Date rape drug detection device and method of using same
WO2025155561A1 (en) *	2024-01-16	2025-07-24	Biovie Inc.	Methods of treating long covid

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6410516B1 (en)	1986-01-09	2002-06-25	President & Fellows Of Harvard College	Nuclear factors associated with transcriptional regulation
US5071773A (en)	1986-10-24	1991-12-10	The Salk Institute For Biological Studies	Hormone receptor-related bioassays
US4898694A (en) *	1987-11-25	1990-02-06	Schwartz Arthur G	17-Hydroxy-steroids
AU7978794A (en) *	1993-10-13	1995-05-04	Neurocrine Biosciences, Inc.	3,17-dihydroxy-3,7,16 and/or 17-methyl-androst-5-ene compounds, derivatives thereof, and their use
US6545027B1 (en)	1995-06-07	2003-04-08	Eli Lilly And Company	Methods of modulating NF-kB transcription factor
US5989835A (en)	1997-02-27	1999-11-23	Cellomics, Inc.	System for cell-based screening
US5753266A (en) *	1996-12-03	1998-05-19	Youssefyeh; Parvin	Safflower seed powder compositions for the treatment of rheumatoid based arthritic diseases
US6667299B1 (en) *	2000-03-16	2003-12-23	Hollis-Eden Pharmaceuticals, Inc.	Pharmaceutical compositions and treatment methods
US20030083231A1 (en) *	1998-11-24	2003-05-01	Ahlem Clarence N.	Blood cell deficiency treatment method
AU2005211675B2 (en) *	1999-03-23	2009-09-24	Harbor Biosciences, Inc.	Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
EP1422234A3 (en) *	1999-03-23	2010-12-08	Harbor BioSciences, Inc.	Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
EP1231264A1 (en) *	1999-08-06	2002-08-14	Glaxo Wellcome, S.A.	New protein
CA2670236C (en) *	1999-09-30	2012-06-05	Hollis-Eden Pharmaceuticals, Inc.	Therapeutic treatment of androgen receptor driven conditions
US6864355B1 (en)	2000-05-02	2005-03-08	Yale University	Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
US6593511B1 (en)	2000-05-12	2003-07-15	Bioseek, Inc.	Models of chronic and acute inflammatory diseases
JP2004537506A (ja) *	2001-03-01	2004-12-16	ホリス − イーデンファーマスーティカルズ、インコーポレイテッド	血液細胞欠乏症を治療するためのある種のステロイドの使用
US6998383B2 (en)	2001-05-11	2006-02-14	Research Development Corporation	Inhibitors of receptor activator of NF-κB and uses thereof
WO2003031578A2 (en) *	2001-10-09	2003-04-17	Immunex Corporation	Mammalian c-type lectins
AU2003278744B2 (en) *	2002-08-28	2010-07-29	Harbor Biosciences, Inc.	Therapeutic treatment methods
AU2003220139A1 (en) *	2002-11-07	2004-06-03	Pharmacia & Upjohn Company Llc	Processes for preparing c-7 substituted 5-androstenes
US7884196B2 (en)	2004-10-06	2011-02-08	Oliver Lawless	Vaccine composition comprising methylated DNA and immunomodulatory motifs

2007
- 2007-04-23 JP JP2009506814A patent/JP5130591B2/ja active Active
- 2007-04-23 EA EA200802167A patent/EA200802167A1/ru unknown
- 2007-04-23 EP EP07863339A patent/EP2012773B1/en active Active
- 2007-04-23 WO PCT/US2007/067235 patent/WO2008039566A2/en not_active Ceased
- 2007-04-23 KR KR1020087028733A patent/KR20080112413A/ko not_active Ceased
- 2007-04-23 EP EP12167186.1A patent/EP2486924B1/en active Active
- 2007-04-23 CA CA2649940A patent/CA2649940C/en active Active
- 2007-04-23 DK DK07863339.3T patent/DK2012773T3/da active
- 2007-04-23 PL PL12167186T patent/PL2486924T3/pl unknown
- 2007-04-23 ES ES07863339T patent/ES2389743T3/es active Active
- 2007-04-23 HU HUE12167186A patent/HUE042925T2/hu unknown
- 2007-04-23 CN CN2013100543094A patent/CN103211821A/zh active Pending
- 2007-04-23 PL PL07863339T patent/PL2012773T3/pl unknown
- 2007-04-23 DK DK12167186.1T patent/DK2486924T3/en active
- 2007-04-23 AU AU2007300404A patent/AU2007300404B2/en not_active Ceased
- 2007-04-23 ES ES12167186T patent/ES2710288T3/es active Active
2008
- 2008-10-22 IL IL194751A patent/IL194751A0/en unknown
2010
- 2010-03-17 AU AU2010201023A patent/AU2010201023B2/en not_active Ceased
2012
- 2012-09-27 JP JP2012214102A patent/JP2012255033A/ja active Pending

Also Published As

Publication number	Publication date
ES2710288T3 (es)	2019-04-24
CA2649940A1 (en)	2008-04-03
JP2012255033A (ja)	2012-12-27
AU2007300404B2 (en)	2009-12-17
JP2009534427A (ja)	2009-09-24
HUE042925T2 (hu)	2019-07-29
CN103211821A (zh)	2013-07-24
EA200802167A1 (ru)	2009-04-28
EP2486924A3 (en)	2013-01-09
EP2486924A2 (en)	2012-08-15
EP2012773B1 (en)	2012-06-20
PL2486924T3 (pl)	2019-07-31
JP5130591B2 (ja)	2013-01-30
WO2008039566A2 (en)	2008-04-03
WO2008039566A3 (en)	2008-11-27
EP2012773A4 (en)	2010-01-13
ES2389743T3 (es)	2012-10-31
EP2012773A2 (en)	2009-01-14
EP2486924B1 (en)	2018-12-26
DK2012773T3 (da)	2012-09-24
KR20080112413A (ko)	2008-12-24
IL194751A0 (en)	2009-08-03
DK2486924T3 (en)	2019-03-04
CA2649940C (en)	2012-08-07
AU2010201023B2 (en)	2012-02-09
AU2007300404A1 (en)	2008-04-03
AU2010201023A1 (en)	2010-04-08

Publication	Publication Date	Title
IL194751A0 (en)	2009-08-03	Drugs and uses
ZA200810323B (en)	2013-05-29	Fkbp-l and uses thereof
PL2064327T3 (pl)	2017-10-31	Dbait i ich zastosowania
TWI561237B (en)	2016-12-11	Substituted dihydropyrazolones and their use
IL205571A0 (en)	2010-12-30	4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin
IL193522A0 (en)	2009-05-04	Pseudoinfectious flavivirus and uses thereof
PL2001556T3 (pl)	2015-03-31	Związki tioniny i ich zastosowanie
ZA200903906B (en)	2010-08-25	Carboranylporphyrins and uses thereof
IL193700A0 (en)	2011-08-01	Medicaments and proteins
ZA200806318B (en)	2009-10-28	Drug combinations
EP2077262A4 (en)	2011-12-28	IMINOPYRIDINE DERIVATIVE AND USE THEREOF
GB0621160D0 (en)	2006-12-06	Compounds and uses thereof
EP2124908A4 (en)	2011-04-27	CONNECTIONS AND ITS USE
IL197883A0 (en)	2009-12-24	Combination drug
GB0611115D0 (en)	2006-07-19	Compounds and their use
EP2120563A4 (en)	2011-04-27	CONNECTIONS AND ITS USES
EP2099459A4 (en)	2011-04-27	COMPOUNDS AND USES THEREOF
GB0619611D0 (en)	2006-11-15	Compounds and their use
GB0610059D0 (en)	2006-06-28	Uses and methods
EP2120957A4 (en)	2011-05-04	COMPOUNDS AND USES THEREOF
GB2444960B (en)	2010-04-28	Combined pseudoscope and hyperscope
GB0621665D0 (en)	2006-12-06	Blogmail and podmail
IL196823A0 (en)	2009-11-18	Tetraarylporphine derivatives and uses thereof
GB0622332D0 (en)	2006-12-20	Drug
ZA200902756B (en)	2010-07-28	Combination drug